Obesity hypoventilation syndrome

Annals of Thoracic Medicine

Volumn 4, Issue 2, 2009, Pages 41-49

  Al Dabal, Laila ^a   BaHammam, Ahmed S ^b  

^a DUBAI HEALTH AUTHORITY   (United Arab Emirates)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Obesity hypoventilation syndrome; Positive pressure ventilation; Sleep disordered breathing

Indexed keywords

ACETAZOLAMIDE; ALMITRINE; AMINOPHYLLINE; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HUMAN; LUNG VENTILATION DISTRIBUTION; OBESITY; OBESITY HYPOVENTILATION SYNDROME; OXYGEN THERAPY; PATHOPHYSIOLOGY; REVIEW; SLEEP APNEA SYNDROME; TRACHEOSTOMY; WEIGHT REDUCTION;

EID: 66749177847     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.49411     Document Type: Review

References (120)

1. Aserinsky E, Kleitman N. Two types of ocular motility occurring in sleep. J Appl Physiol 1955;8:1-10.
2. Sinton CM, McCarley RW. Neurophysiological mechanisms of sleep and wakefulness: A question of balance. Semin Neurol 2004;24:211-23.
3. Eldridge FL. Central nervous system and chemoreceptor factors in control of breathing. Chest 1978;73:256-8.
4. 2 stimulus threshold for carotid chemoreceptors and breathing. Respir Physiol 1978;34:359-75.
5. O'Regan RG, Majcherczyk S. Role of peripheral chemoreceptors and cential chemosensitivity in the regulation of respiration and circulation. J Exp Biol 1982;100:23-40.
6. Dempsey JA, Smith CA, Harms CA, Chow C, Saupe KW. Sleep-induced breathing instability: University of Wisconsin-Madison Sleep and respiration Research Group. Sleep 1996;19:236-47.
7. Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in normal man. Thorax 1982;37:840-4.
8. Krieger J. Breathing during sleep in normal subjects. Clin Chest Med 1985;6:577-94.
9. Ancoli-Israel S, Kripke DF, Mason W. Characteristics of obstructive and cential sleep apnea in the elderly: An interim report. Biol Psychiatry 1987;22:741-50.
10. rd, Monk TH, Buysse DJ, Yeager AL, Houck PR, et al. Comparison of sleep-disordered breathing among healthy elderly in the seventh, eighth, and ninth decades of life. Sleep 1990;13:502-ll.
11. Kreis P, Kripke DF, Ancoli-Israel S. Sleep apnea: A prospective study. West J Med. 1983;139:171-3.
12. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
13. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136-43.
14. World Health Organization: Obesity. (Updated periodically throughout the year). Available from: http://www.who.int/topics/obesity/en/, [cited on 2008 Oct30].
15. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000;118:1315-21.
16. Collins LC, Hoberty PD, Walker JF, Fletcher EC, Peiris AN. The effect of body fat distribution on pulmonary function tests. Chest 1995;107:1298-302.
17. Pischon T, Boeing H, Hoffmannm K, Bergmann M, Schulze M, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-20.
18. Ladosky W, Botelho MA, Albuquerque JP Jr. Chest mechanics in morbidly obese non-hypoventilated patients. Respir Med 2001;95:281-6.
19. Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest 2006;130:827-33.
20. Teixeira CA, Dos Santos JE, Silva GA, de Souza ES, Martinez JA. Prevalence of and the potential physiopathological mechanisms involved in dyspnea in individuals with class II or III obesity. J Bras Pneumol 2007;33:28-35.
21. Zerah F, Harf A, Perlemuter L, Lorino H, Lorino AM, Atlan G. Effects of obesity on respiratory resistance. Chest 1993;103:1470-6.
22. Koenig SM. Pulmonary complications of obesity. Am J Med Sci 2001;321:249-79.
23. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: Prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007;11:117-24.
24. BaHammam A. Positive airway pressure therapy and daytime hypercapnia in patients with sleep-disordered breathing. Chest. 2008;134:218-9.
25. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005;118:948-56.
26. The Report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-89.
27. Akashiba T, Akahoshi T, Kawahara S, Uematsu A, Katsura K, Sakurai S, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: A multicenter study. Intern Med 2006;45: 1121-5.
28. Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, et al. The obesity-hypoventilation syndrome revisited: A prospective study of 34 consecutive cases. Chest 2001; 120:369-76.
29. Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005;127:710-5.
30. Resta O, Bonfitto P, Sabato R, De Pergola G, Barbaro MP. Prevalence of obstructive sleep apnoea in a sample of obese women: Effect of menopause. Diabetes Nutr Metab 2004;17: 296-303.
31. Verin E, Tardif C, Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med 2001;95:693-6.
32. Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, et al. Obesity-associated hypoventilation in hospitalized patients: Prevalence, effects, and outcome. Am J Med 2004;116:1-7.
33. Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest 2001;120:377-83.
34. Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc 2008;5:218-25.
35. Imagawa S, Yamaguchi Y, Ogawa K, Obara N, Suzuki N, Yamamoto M, et al. Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration 2004;71:24-9.
36. Osborn O, Gram H, Zorrilla E, Conti B, Bartfai T. Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance. Swiss Med Wkly 2008;138:665-73.
37. Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007;30:29-34.
38. Vgontzas AN. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Arch Physiol Biochem 2008;114:211-23.
39. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-6.
40. Zamarron C, Garcia Paz V, Riveiro A. Obstructive sleep apnea syndrome is a systemic disease: Current evidence. Eur J Intern Med 2008;19:390-8.
41. Hatipoglu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: A working hypothesis. Respiration 2003;70:665-71.
42. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998;18:559-72.
43. Shimura R, Tatsumi K, Nakamura A, Kasahara Y, Tanabe N, Takiguchi Y, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apneahypopnea syndrome. Chest 2005;127: 543-9.
44. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
45. Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax 2002;57:75-6.
46. Atwood CW. Sleep-related hypoventilation: The evolving role of leptin. Chest 2005;128:1079-81.
47. Campo A, Fruhbeck G, Zulueta JJ, Iriarte J, Seijo LM, Alcaide AB, et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J 2007;30:223-31.
48. Perez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vazquez Caruncho M, Caballero Muinelos O, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesityhypoventilation syndrome. Chest 2005;128:587-94.
49. Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome: A reevaluation of the "Pickwickian syndrome". Chest 1986;89:627-35.
50. Mokhlesi B, Tulaimat A, Evans AT, Wang Y, Itani AA, Hassaballa HA, et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med 2006;2:57-62.
51. Han F, Chen E, Wei H, He Q, Ding D, Strohl KP. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2001;119:1814-9.
52. Kawata N, Tatsumi K, Terada J, Tada Y, Tanabe N, Takiguchi Y, et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest 2007;132:1832-8.
53. Garay SM, Rapoport D, Sorkin B, Epstein H, Feinberg I, Goldring RM. Regulation of ventilation in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1981;124:451-7.
54. Javaheri S, Colangelo G, Lacey W, Gartside PS. Chronic hypercapnia in obstructive sleep apnea-hypopnea syndrome. Sleep 1994;17:416-23.
55. Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV. Decreased hypoxic ventilatory drive in the obesityhypoventilation syndrome. Am J Med 1975;59:343-8.
56. Gold AR, Schwartz AR, Wise RA, Smith PL. Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest 1993;103:1325-9.
57. Ahmed Q, Chung-Park M, Tomashefski JF, Jr. Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. Hum Pathol 1997;28:264-9.
58. Scheuller M, Weider D. Bariatric surgery for treatment of sleep apnea syndrome in 15 morbidly obese patients: Long-term results. Otolaryngol Head Neck Surg 2001;125:299-302.
59. Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, et al. Practice parameters for the indications for polysomnography and related procedures: An update for 2005. Sleep 2005;28:499-521.
60. BaHammam A, Syed S, Al-Mughairy A. Sleep-related breathing disorders in obese patients presenting with acute respiratory failure. Respir Med 2005;99:718-25.
61. Bahammam A, Kryger M. Decision making in obstructive sleep-disordered breathing: Putting it all together. Clin Chest Med 1998;19:87-97.
62. Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004;125:2046-52.
63. Sampol G, Munoz X, Sagales MT, Marti S, Roca A, Dolors de la Calzada M, et al. Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome. Eur Respir J 1998;12:1156-9.
64. Guardiano SA, Scott JA, Ware JC, Schechner SA. The long-term results of gastric bypass on indexes of sleep apnea. Chest 2003;124:1615-9.
65. Varela JE, Hinojosa MW, Nguyen NT. Resolution of obstructive sleep apnea after laparoscopic gastric bypass. Obestet Surg 2007;17:1279-82.
66. Marti-Valeri C, Sabate A, Masdevall C, Dalmau A. Improvement of associated respiratory problems in morbidly obese patients after open Roux-en-Y gastric bypass. Obestet Surg 2007;17: 1102-10.
67. Davila-Cervantes A, Dominguez-Cherit G, Borunda D, Gamino R, Vargas-Vorackova F, Gonzalez-Barranco J, et al. Impact of surgically-induced weight loss on respiratory function: A prospective analysis. Obestet Surg 2004;14:1389-92.
68. Weiner P, Waizman J, Weiner M, Rabner M, Magadle R, Zamir D. Influence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. Thorax 1998;53:39-42.
69. El-Gamal H, Khayat A, Shikora S, Unterborn JN. Relationship of dyspnea to respiratory drive and pulmonary function tests in obese patients before and after weight loss. Chest 2005;128:3870-4.
70. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292:1724-37.
71. Fernandez AZ Jr, Demaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg 2004;239:698-702; discussion-3.
72. Carmody BJ, Sugerman HJ, Kellum JM, Jamal MK, Johnson JM, Carbonell AM, et al. Pulmonary embolism complicating bariatric surgery: Detailed analysis of a single institution's 24-year experience. J Am Coll Surg 2006;203:831-7.
73. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The North American Association for the Study of Obesity (NAASO) and the National Heart, Lung, and Blood Institute (NHLBI). 2000.
74. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001;163:540-77.
75. Resta O, Guido P, Picca V, Sabato R, Rizzi M, Scarpelli F, et al. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study. Respir Med 1998;92:820-7.
76. Shivaram U, Cash ME, Beal A. Nasal continuous positive airway pressure in decompensated hypercapnic respiratory failure as a complication of sleep apnea. Chest 1993;104:770-4.
77. Goldstein RS, De Rosie JA, A vendano MA, Dolmage TE. Influence of noninvasive positive pressure ventilation on inspiratory muscles. Chest 1991;99:408-15.
78. Heinemann F, Budweiser S, Dobroschke J, Pfeifer M. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med 2007;101:1229-35.
79. Pankow W, Hijjeh N, Schuttler F, Penzel T, Peter JH, von Wichert P. Effect of noninvasive ventilation on work of breathing in obesity. Med Klin (Munich) 1997;92:54-60.
80. Patel RG, Petrini MF. Respiratory muscle performance, pulmonary mechanics, and gas exchange between the BiPAP S/T-D system and the Servo Ventilator 900C with bilevel positive airway pressure ventilation following gradual pressure support weaning. Chest 1998;114:1390-6.
81. 2 re-breathing before and after nocturnal nasal intermittent positive pressure ventilation in patients with chronic alveolar hypoventilation. Respir Med 2000;94:1154-60.
82. Sullivan CE, Berthon-Jones M, Issa FG. Remission of severe obesityhypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am Rev Respir Dis 1983;128:177-81.
83. Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 2008;63:395-401.
84. Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: Hypoxemia during continuous positive airway pressure. Chest 2007;131:1678-84.
85. Schafer H, Ewig S, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: Predictive factors and treatment with bilevelpositive airway pressure. Respir Med 1998;92:208-15.
86. Berger KI, Ayappa I, Chatr-Amontri B, Marfatia A, Sorkin IB, Rapoport DM, et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 2001;120:1231-8.
87. Waldhorn RE. Nocturnal nasal intermittent positive pressure ventilation with bi-level positive airway pressure (BiPAP) in respiratory failure. Chest 1992;101:516-21.
88. Loube DI GP, Strohl KP, Pack Al, White DP, Collop NA. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: A consensus Statement. Chest 1999;115:863-6.
89. Piper AJ, Sullivan CE. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994;105:434-40.
90. Carratu P, Karageorgiou G, Bonfitto P, Di Gioia G, Lacedonia D, Barbaro MP, et al. Long-term evaluation of mental fatigue by Maastricht Questionnaire in patients with OSAS treated with CPAP. Monaldi Arch Chest Dis 2007;67:6-9.
91. Hida W, Okabe S, Tatsumi K, Kimura H, Akasiba T, Chin K, et al. Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath 2003;7:3-12.
92. Kawahara S, Akashiba T, Akahoshi T, Horie T. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 2005;44:422-7.
93. Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J 2000;16:118-22.
94. Budweiser S, Riedl SG, Jorres RA, Heinemann F, Pfeifer M. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med 2007;261:375-83.
95. Storre JH, Seuthe B, Fiechter R, Milioglou S, Dreher M, Sorichter S, et al. Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest. 2006 Sep; 130:815-21.
96. Masa JF, Celli BR, Riesco JA, Sanchez de Cos J, Disdier C, Sojo A. Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases. Chest 1997;112:207-13.
97. Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: Hypoxemia during continuous positive airway pressure. Chest 2007;131:1678-84.
98. Perez de Llano LA, Golpe R, Piquer MO, Racamonde AV, Caruncho MV, Lopez MJ, et al. Clinical heterogeneity among patients with obesity hypoventilation syndrome: Therapeutic implications. Respiration 2008;75:34-9.
99. 2 after tracheostomy in obstructive sleep apnea syndrome. Am Rev Respir Dis 1982;126:14-20.
100. Kim SH, Eisele DW, Smith PL, Schneider H, Schwartz AR. Evaluation of patients with sleep apnea after tracheotomy. Arch Otolaryngol Head Neck Surg 1998;124:996-1000.
101. Rapoport DM, Sorkin B, Garay SM, Goldring RM. Reversal of the "Pickwickian syndrome" by long-term use of nocturnal nasal-airway pressure. N Engl J Med 1982;307:931-3.
102. Sugita Y, Wakamatsu H, Teshima Y, Tanaka K, Furuya E, Masaoka S, et al. Therapeutic effects of tracheostomy in two cases of hypersomnia with respiratory disturbance during sleep. Folia Psychiatr Neurol Jpn 1980;34:17-25.
103. Koziej M, Mankowski M, Radwan L, Maszczyk Z. Obesity and hypoventilation syndrome: Effects of weight loss and treatment with respiratory stimulants. Pneumonol Alergol Pol 1996;64: 687-96.
104. Marrone O, Milone F, Coppola P, Oddo S, Giannone G, Macaluso C, et al. Effects of almitrine bismesylate on nocturnal hypoxemia in patients with chronic bronchitis and obesity. Eur J Respir Dis Suppl 1986;146:641-8.
105. Pena F, Garcia O. Breathing generation and potential pharmacotherapeutic approaches to central respiratory disorders. Curr Med Chem 2006;13:2681-93.
106. Rajagopal KR, Abbrecht PH, Jabbari B. Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 1986;90:815-21.
107. McKenzie R, Wadhwa RK. Progesterone for the Pickwickian syndrome: Respiratory implications: A case report. Anesth Analg 1977;56:133-5.
108. Skatrud JB, Dempsey JA, Kaiser DG. Ventilatory response to medroxyprogesterone acetate in normal subjects: Time course and mechanism. J Appl Physiol 1978;44:393-44.
109. Sutton FD Jr, Zwillich CW, Creagh CE, Pierson DJ, Weil JV. Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med 1975;83:476-9.
110. Saaresranta T, Irjala K, Polo O. Effect of medroxyprogesterone on arterial blood gases, leptin and neuropeptide Y in postmenopausal females. Eur Respir J 2002;20:1413-8.
111. Poulter NR, Chang CL, Farley TM, Meirik O. Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications. Lancet 1999;35419:1610.
112. Sare GM, Gray LJ, Bath PM. Association between hormone replacement therapy and subsequent arterial and venous vascular events: A meta-analysis. Eur Heart J 2008;29:2031-41.
113. Swenson ER. Carbonic anhydrase inhibitors and ventilation: A complex interplay of stimulation and suppression. Eur Respir J 1998;12:1242-7.
114. Teppema LJ, Dahan A. Acetazolamide and breathing: Does a clinical dose alter peripheral and central CO sensitivity? Am J Respir Crit Care Med 1999;160:1592-7.
115. Haque AK, Gadre S, Taylor J, Haque SA, Freeman D, Duarte A. Pulmonary and cardiovascular complications of obesity: An autopsy study of 76 obese subjects. Arch Pathol Lab Med 2008;132:1397-404.
116. Lam JC, Ip MS. An update on obstructive sleep apnea and the metabolic syndrome. Curr Opin Pulm Med 2007;13:484-9.
117. Goldman JM, Ireland RM, Berthon-Jones M, Grunstein RR, Sullivan CE, Biggs JC. Erythropoietin concentrations in obstructive sleep apnoea. Thorax 1991;46:25-7.
118. DeFilippis AP, Law K, Curtin S, Eckman JR. Blood is thicker than water: The management of hyperviscosity in adults with cyanotic heart disease. Cardiol Rev 2007;15:31-4.
119. Marathias KP, Agroyannis B, Mavromoustakos T, Matsoukas J, Vlahakos DV. Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Curr Top Med Chem 2004;4:483-6.
120. Rell K, Koziak K, Jarzyo I, Lao M, Gaciong Z. Correction of post-transplant erythrocytosis with enalapril. Transplantation 1994;57:1059-63.